.
Abstract
National patent applications in biotechnology, subclass C12N, in Brazil from 1998 to 2000. Only 11% of the activities of research and development in Brazil are carried out in private institutions. In the biotechnological field, an area of knowledge significantly closer to the basic sciences, there is a higher participation of public sectors, as might be expected. Among the public institutions, the universities were responsible for the highest number of applications in the evaluated time period, 56%. The national participation in the number of biotechnological patent applications in Brazil was 2.6% from 1998 to 2000. Among the countries with the highest number of biotech nological patent applications in Brazil, there is an obvious domination of the United States of America, representing 51.5% of all countries in 1999 and 42.3% of the 1057 C12N patent applications. Applications in the C12N 15 classification with 31.5% were the most frequent in comparison with the other C12N applications. This fact shows the fast increase of the number of applications in genetic engineering and fields of recombinant DNA technology. This result is a possible consequence of the genome race that is occurring at world level.Downloads
Published
2006-01-01
Issue
Section
Artigos
License
Copyright (c) 2006 Maria Hercília Paim Fortes, Celso Luiz Salgueiro Lage

This work is licensed under a Creative Commons Attribution 4.0 International License.
After the electronic publication of the manuscript, the authors are entitled, without any restriction, on its contents.
License Creative Commons Atribuição 4.0 Internacional - CC BY
Authors are able to take on additional contracts separately, non-exclusive distribution of the version of the paper published in this journal (ex.: publish in institutional repository or as a book), with an acknowledgment of its initial publication in this journal.

